Subpial transection surgery for epilepsy

Background Nearly 30% of patients with epilepsy continue to have seizures despite using several antiepileptic drugs (AEDs). Such patients are regarded as having refractory, or uncontrolled, epilepsy. While there is no universally accepted definition of uncontrolled, or medically refractory, epilepsy...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cochrane database of systematic reviews 2018-11, Vol.2018 (11), p.CD008153-CD008153
Hauptverfasser: Krishnaiah, Balaji, Ramaratnam, Sridharan, Ranganathan, Lakshmi Narasimhan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Nearly 30% of patients with epilepsy continue to have seizures despite using several antiepileptic drugs (AEDs). Such patients are regarded as having refractory, or uncontrolled, epilepsy. While there is no universally accepted definition of uncontrolled, or medically refractory, epilepsy, for the purposes of this review we will consider seizures as drug resistant if they have failed to respond to a minimum of two AEDs. Specialists consider that early surgical intervention may prevent seizures at a younger age, which in turn may improve the intellectual and social status of children. Many types of surgery are available for treating refractory epilepsy; one such procedure is known as subpial transection. Objectives To assess the effects of subpial transection for focal‐onset seizures and generalised tonic‐clonic seizures in children and adults. Search methods For the latest update we searched the following databases on 7 August 2018: the Cochrane Register of Studies (CRS Web), which includes the Cochrane Epilepsy Group Specialized Register and the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (Ovid, 1946 to August 06, 2018), ClinicalTrials.gov, and the WHO International Clinical Trials Registry Platform (ICTRP). We imposed no language restrictions. Selection criteria We considered all randomised and quasi‐randomised parallel‐group studies, whether blinded or non‐blinded. Data collection and analysis Two review authors (BK and SR) independently screened trials identified by the search. The same two review authors planned to independently assess the methodological quality of studies. Had we identified studies for inclusion, one review author would have extracted the data, and the other would have verified the data. Main results We found no relevant studies. Authors' conclusions We found no evidence to support or refute the use of subpial transection surgery for patients with medically refractory epilepsy. Well‐designed randomised controlled trials are needed to guide clinical practice.
ISSN:1465-1858
1465-1858
1469-493X
DOI:10.1002/14651858.CD008153.pub4